Additionally, molecular analysis of PLCB4 and CYSLTR2 [59,60,61] and methylation profiling are especially useful in discriminating these lesions from other pigmented CNS tumors [1,59]. The gene discussed is CYSLTR2; the disease is central nervous system neoplasm.